Clones and drones: Do variants of Panton-Valentine leukocidin extend the reach of community-associated methicillin-resistant Staphylococcus aureus?

Journal of Infectious Diseases

Volumn 197, Issue 2, 2008, Pages 175-178

  John Jr , Joseph F ^a,b,d   Lindsay, Jodi A ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PANTON VALENTINE LEUKOCIDIN; STAPHYLOCOCCUS TOXIN; BACTERIAL TOXIN; EXOTOXIN; FUSED HETEROCYCLIC RINGS; LEUKOCIDIN; PANTON-VALENTINE LEUKOCIDIN; RETAPAMULIN; UNCLASSIFIED DRUG;

BACTERIAL STRAIN; BACTERIAL VIRULENCE; EMERGENCY WARD; HUMAN; IMMUNE RESPONSE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOTE; NUCLEOTIDE SEQUENCE; PHAGOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS INFECTION; AMINO ACID SUBSTITUTION; ANIMAL; CLASSIFICATION; CLINICAL TRIAL; COMMUNICABLE DISEASE; DRUG EFFECT; GENETIC VARIABILITY; GENETICS; MICROBIOLOGY; MOUSE; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS;

AMINO ACID SUBSTITUTION; ANIMALS; BACTERIAL TOXINS; BICYCLO COMPOUNDS, HETEROCYCLIC; CLINICAL TRIALS AS TOPIC; COMMUNITY-ACQUIRED INFECTIONS; ELECTROPHORESIS, GEL, PULSED-FIELD; EXOTOXINS; HUMANS; LEUKOCIDINS; METHICILLIN RESISTANCE; MICE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VARIATION (GENETICS);

EID: 39149132859     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/524693     Document Type: Note

References (30)

1. Panton PN, Valentine FCO. Staphylococcal toxin. Lancet 1932; 1:506-8.
2. O'Hara FP, Guex N, Word JM, et al. A geographic variant of the Staphylococcus aureus Panton-Valentine leukocidin toxin and the origin of community-associated methicillin-resistant S. aureus USA300. J Infect Dis 2008; 197:187-92 (in this issue).
3. Jevons MP. "Celbenin"-resistant staphylococci. Br Med J 1961; 1:124-5.
4. Panton PN, Valentine FCO, Dix VW. Staphylococcal infection and antitoxin treatment. Lancet 1931; 2:1180-3.
5. Lina G, Piemont Y, Godail-Gamont F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29:1128-32.
6. John JF. Drug evaluation: tefibazumab - a monoclonal antibody against staphylococcal infection. Curr Opin Mol Ther 2006; 8:455-60.
7. Voyich JM, Otto M, Mathema B, Braughton KR, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 2006; 194:1761-70.
8. Gillet Y, Vanhems P, Lina G, et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis 2007; 45:315-21.
9. Labandiera-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007; 315:1130-3.
10. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S .aureus infections among patients in the emergency department. N Engl J Med 2006; 355:666-74.
11. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003; 41: 5113-20.
12. Centers for Disease Control and Prevention. Public health dispatch: outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections - Los Angeles County, California, 2002-2003. MMWR Morb Mortal Wkly Rep 2003; 52:88.
13. Ito T, Ma XX, Takeuchi F, Okuma K, Yuzawa H, Hiramatsu K. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother 2004; 48:2637-51.
14. Deurenberg RH, Vink C, Kalenic S, et al. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2007; 13:222-35.
15. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352:1445-53.
16. Hota B, Ellenbogen C, Hayden MK, Aroutcheva A, Rice TW, Weinstein RA. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections at a public hospital: do public housing and incarceration amplify transmission? Arch Intern Med 2007; 167:1026-33.
17. Gonzalez BE, Rueda AM, Shelburne SA, et al. Community-acquired methicillin-resistant Staphylococcus aureus as the cause of healthcare-associated infection. Infect Control Hosp Epidemiol 2006; 27:1051-6.
18. Diep BA, Carleton HA, Chang RF, et al. Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin resistant Staphylococcus aureus. J Infect Dis 2006; 193:1495-1503.
19. Larsen AR, Stegger M, Goering RV, et al. Emergence and dissemination of the methicillin resistant Staphylococcus aureus USA300 clone in Denmark (2000-2005). Euro Surveill 2007; 12 (electronically published ahead of print).
20. Daum RS. Clinical practice: skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med 2007; 357:380-90.
21. Naimi TS, LeDell KH, Como-Satetti K, et al. Comparison of community- and health care-associated methicillin resistant Staphylococcus aureus infection. JAMA 2003; 290:2976-84.
22. Lindsay JA, Moore CE, Day NP, et al. Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes. J Bacteriol 2006; 188:669-76.
23. Lindsay J, Holden MT. Staphylococcus aureus: superbug, super genome? Trends Microbiol 2004; 12:378-85.
24. Narita S, Kaneko J, Chiba J, et al. Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus: molecular analysis of a PVL-converting phage, phiSLT. Gene 2001; 268:195-206.
25. Tristan A, Bes, M, Meugnier H, et al. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 2007; 13:594-600.
26. Wolter DJ, Tenover FC, Goering RV. Allelic variation in genes encoding Panton-Valentine leukocidin from community-associated Staphylococcus aureus. Clin Microbiol Infect 2007; 13:827-30.
27. van Wamel WJ, Rooijakkers SH, Ruyken M, van Kessel KP, van Strijp JA. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. J Bacteriol 2006; 188:1310-5.
28. Waldron DE, Lindsay JA. Sau1: a novel lineage-specific type I restriction-modification system that blocks horizontal gene transfer into Staphylococcus aureus and between S. aureus isolates of different lineages. J Bacteriol 2006; 188:5578-85.
29. Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet 2006; 367:731-9.
30. Obituary: Sir Philip Panton. J Clin Pathol 1951; 4:109-11.